Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
5216 participants
OBSERVATIONAL
2018-11-20
2023-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group
The pregnancy women without any diseases.
No intervention
No intervention
Disease Group
The pregnancy women with cardio-metabolic and endocrinic disorders such as gestational diabetes, obesity, hypertension, thyroid diseases, anemia and other cardio-metabolic diseases.
No intervention
No intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
No intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pregnant women who have resided in Huizhou for at least 3 years;
* Pregnant women who are consent for specimens and data collection and follow-ups for both mother and infant.
Exclusion Criteria
* Pregnant women who refuse to participate or be unwilling to sign informed consent;
* Pregnant women who are mentally incapacitated and need guardians.
18 Years
49 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Huizhou No.1 Maternal and Child Care Service Cencer
UNKNOWN
Sun Yat-sen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
LIU ZHAOMIN
Professor in Department of Nutrition and Food Hygiene
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zhaomin Liu, Doctor
Role: PRINCIPAL_INVESTIGATOR
School of Public Health of Sun Yat-sen University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
School of Public Health of Sun Yat-sen University (North Campus)
Guangzhou, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Liu ZM, Long HH, Li D, Fang AP, Chen CG, Wang C, Li MM, Wu Y, Zhang SJ, Pan WJ. Maternal Serum Iodine Concentrations in Early Pregnancy Exhibited Well Diagnostic Ability for Thyroid Dysfunction, Inverse Associations with Gestational Weight Gain, and Birth Size: Longitudinal Analyses Based on Huizhou Mother-Infant Cohort. Biol Trace Elem Res. 2025 Jul;203(7):3618-3629. doi: 10.1007/s12011-024-04443-7. Epub 2024 Nov 29.
Zhang D, Zhang S, Li G, Lai Y, Hao YT, Chen WQ, Wu Y, Chen C, Pan W, Liu ZM. A clinical model and nomogram for early prediction of gestational diabetes based on common maternal demographics and routine clinical parameters. J Obstet Gynaecol Res. 2022 Nov;48(11):2738-2747. doi: 10.1111/jog.15380. Epub 2022 Jul 31.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HZT2018
Identifier Type: -
Identifier Source: org_study_id